Skip to content
  • About
    • Supporter
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjdementia
VJNeurology
Logo
  • Home (current)
  • Diseases
    Parkinson's Disease
    Multiple Sclerosis and Related Disorders
    Headache
    Amyotrophic Lateral Sclerosis
    Epilepsy
    Sleep Disorders
    Stroke
    Neuromuscular Disorders
    Movement Disorders
    View all Diseases
  • Topics
    Biology
    Diagnostics
    Trial Updates
    Treatment
    Prevention
    Surgery
    Imaging
    Genetics
    COVID-19
    View all Topics
  • Conferences
    EHC 2022
    AES 2022
    WSC 2022
    ECTRIMS 2022
    EHDN 2022
    MDS 2022
    View all Conferences
  • Features
  • Podcasts
    • About
      • Supporter
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

Xavier Montalban

Assessing remibrutinib in patients with relapsing MS 0:38
Assessing remibrutinib in patients with relapsing MS
Xavier Montalban • 4 Apr 2022
Addressing unanswered questions in MS at AAN 2022 0:50
Addressing unanswered questions in MS at AAN 2022
Xavier Montalban • 4 Apr 2022
Prospective cohorts on CIS and treated patients with mutiple sclerosis 1:07
Prospective cohorts on CIS and treated patients with mutiple sclerosis
Xavier Montalban • 3 Apr 2022
The safety and efficacy of evobrutinib in multiple sclerosis 1:15
The safety and efficacy of evobrutinib in multiple sclerosis
Xavier Montalban • 8 Mar 2022
Understanding the earliest stages of multiple sclerosis 1:10
Understanding the earliest stages of multiple sclerosis
Xavier Montalban • 8 Mar 2022
Using DMTs beyond patients with active MS 3:14
Using DMTs beyond patients with active MS
Xavier Montalban • 29 Mar 2022
Differential efficacy of DMTs in patients with active and inactive MS 1:30
Differential efficacy of DMTs in patients with active and inactive MS
Xavier Montalban • 29 Mar 2022
Future areas of improvement in treating MS 0:58
Future areas of improvement in treating MS
Xavier Montalban • 29 Mar 2022
Using digital technology to facilitate MS management 1:20
Using digital technology to facilitate MS management
Xavier Montalban • 29 Mar 2022
The diagnostic and therapeutic landscape of MS in 2021 2:08
The diagnostic and therapeutic landscape of MS in 2021
Xavier Montalban • 23 Sep 2021
Neuroregenerative agents in progressive multiple sclerosis 1:08
Neuroregenerative agents in progressive multiple sclerosis
Xavier Montalban • 23 Sep 2021
Future directions for progressive multiple sclerosis 2:17
Future directions for progressive multiple sclerosis
Xavier Montalban • 23 Sep 2021
Current treatments for primary and secondary progressive multiple sclerosis 4:46
Current treatments for primary and secondary progressive multiple sclerosis
Xavier Montalban • 23 Sep 2021
Journal Pages
  • Diseases
  • Topics
  • Medicines
  • Trials
  • Conferences
  • Features
Newsletter

Receive the latest news and videos from VJNeurology via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJNeurology logo
The content of VJNeurology is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy